It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
Germany: Why Does So Much Take So Long?
-
Portugal: Expiration term to bring arbitration in patents v generics, Supreme Court of Justice of Portugal, 554/15.7YRLSB.L1.S1, 07 December 2016
-
Pharmaq AS v. Intervet International B.V., Court of Appeal, (Borgarting Appelate Court) 22 December 2011
-
NL – Sisvel v. Xiaomi – PI based on SEP denied
-
Adminstrative Council urged to help end ‘persistent atmosphere of intimidation’ at the EPO
-
Polschuhbleche (Dringlichkeit im Besichtigungsverfahren), Court of Appeal Düsseldorf (Oberlandsgericht Düsseldorf), 17 March 2011
-
Gedeon Richter plc v Bayer Schering Pharma AG [2012] EWCA Civ 235
-
Process for improving glucose metabolism, European Patent Office (Appeals Court), 19 December 2012
-
Top 10 Posts on the Kluwer Patent Blog in 2015
-
EPO publishes draft Strategic Plan 2023 and holds a new consultation